{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:20:32Z","timestamp":1783185632714,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-023-04440-w","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T08:02:27Z","timestamp":1684915347000},"page":"1975-1982","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Complications associated with minimally invasive surgical therapies (MIST) for surgical management of benign prostatic hyperplasia: a Manufacturer and User Facility Device Experience (MAUDE) database review"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6495-1054","authenticated-orcid":false,"given":"Joao G.","family":"Porto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-9174","authenticated-orcid":false,"given":"Maria Camila Suarez","family":"Arbelaez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-0805","authenticated-orcid":false,"given":"Ruben","family":"Blachman-Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6131-4837","authenticated-orcid":false,"given":"Ansh","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6610-2550","authenticated-orcid":false,"given":"Shivank","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramgopal","family":"Satyanarayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Marcovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4273-5502","authenticated-orcid":false,"given":"Hemendra N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"4440_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)49698-4","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol. https:\/\/doi.org\/10.1016\/S0022-5347(17)49698-4","journal-title":"J Urol"},{"key":"4440_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002183","author":"LB Lerner","year":"2021","unstructured":"Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, Gandhi MC, Kaplan SA, Kohler TS, Martin L, Parsons JK, Roehrborn CG, Stoffel JT, Welliver C, Wilt TJ (2021) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-initial work-up and medical management. J Urol. https:\/\/doi.org\/10.1097\/JU.0000000000002183","journal-title":"J Urol"},{"key":"4440_CR3","unstructured":"Gravas S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, Rieken M, Speakman MJ, Tikkinen KAO, Guidelines Associates: Karavitakis M, Kyriazis I, Malde S, Sakalis V, Guidelines Office: Schouten N, Smith EJ (2022) EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). In: Presented at the EAU annual congress Amsterdam 2022"},{"key":"4440_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2021.08.009","author":"E Checcucci","year":"2021","unstructured":"Checcucci E et al (2021) New ultra-minimally invasive surgical treatment for benign prostatic hyperplasia: a systematic review and analysis of comparative outcomes. Eur Urol Open Sci. https:\/\/doi.org\/10.1016\/j.euros.2021.08.009","journal-title":"Eur Urol Open Sci"},{"key":"4440_CR5","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6051.21.04530-4","author":"C Manfredi","year":"2022","unstructured":"Manfredi C et al (2022) Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications. Minerva Urol Nephrol. https:\/\/doi.org\/10.23736\/S2724-6051.21.04530-4","journal-title":"Minerva Urol Nephrol"},{"key":"4440_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2020.07.006","author":"D Bouhadana","year":"2020","unstructured":"Bouhadana D, Nguyen D-D, Zorn KC, Elterman DS, Bhojani N (2020) Patient perspectives on benign prostatic hyperplasia surgery: a focus on sexual health. J Sex Med. https:\/\/doi.org\/10.1016\/j.jsxm.2020.07.006","journal-title":"J Sex Med"},{"key":"4440_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e318161e657","author":"SE Gurtcheff","year":"2008","unstructured":"Gurtcheff SE (2008) Introduction to the MAUDE Database. Clin Obstet Gynecol. https:\/\/doi.org\/10.1097\/GRF.0b013e318161e657","journal-title":"Clin Obstet Gynecol"},{"key":"4440_CR8","unstructured":"MAUDE\u2014Manufacturer and User Facility Device Experience. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/search.cfm"},{"key":"4440_CR9","doi-asserted-by":"publisher","DOI":"10.1089\/end.2021.0455","author":"E Kaplan-Marans","year":"2022","unstructured":"Kaplan-Marans E, Martinez M, Wood A, Cochran J, Dubowitch E, Schulman A (2022) Aquablation, prostatic urethral lift, and transurethral water vapor therapy: a comparison of device-related adverse events in a national registry. J Endourol. https:\/\/doi.org\/10.1089\/end.2021.0455","journal-title":"J Endourol"},{"key":"4440_CR10","doi-asserted-by":"publisher","DOI":"10.1089\/end.2019.0067","author":"NH Patel","year":"2019","unstructured":"Patel NH et al (2019) Device malfunctions and complications associated with benign prostatic hyperplasia surgery: review of the manufacturer and user facility device experience database. J Endourol. https:\/\/doi.org\/10.1089\/end.2019.0067","journal-title":"J Endourol"},{"key":"4440_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2021.04.030","author":"JK Weiss","year":"2021","unstructured":"Weiss JK, Santucci NM, Sajadi KP, Chouhan JD (2021) Post-surgical complications after bladder outlet reducing surgery: an analysis of the FDA manufacturer and user facility device experience (MAUDE) database. Urology. https:\/\/doi.org\/10.1016\/j.urology.2021.04.030","journal-title":"Urology"},{"key":"4440_CR12","doi-asserted-by":"publisher","DOI":"10.1089\/end.2016.0396","author":"P Gupta","year":"2017","unstructured":"Gupta P et al (2017) Development of a classification scheme for examining adverse events associated with medical devices, specifically the DaVinci surgical system as reported in the FDA MAUDE database. J Endourol. https:\/\/doi.org\/10.1089\/end.2016.0396","journal-title":"J Endourol"},{"key":"4440_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.10.181","author":"KT McVary","year":"2016","unstructured":"McVary KT et al (2016) Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. https:\/\/doi.org\/10.1016\/j.juro.2015.10.181","journal-title":"J Urol"},{"key":"4440_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.03.372","author":"KT McVary","year":"2016","unstructured":"McVary KT et al (2016) Erectile and ejaculatory function preserved with convective water vapor energy treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: randomized controlled study. J Sex Med. https:\/\/doi.org\/10.1016\/j.jsxm.2016.03.372","journal-title":"J Sex Med"},{"key":"4440_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2018.12.041","author":"KT McVary","year":"2019","unstructured":"McVary KT, Rogers T, Roehrborn CG (2019) Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology. https:\/\/doi.org\/10.1016\/j.urology.2018.12.041","journal-title":"Urology"},{"key":"4440_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10342.x","author":"HH Woo","year":"2011","unstructured":"Woo HH, Chin PT, McNicholas TA, Gill HS, Plante MK, Bruskewitz RC, Roehrborn CG (2011) Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10342.x","journal-title":"BJU Int"},{"key":"4440_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15653","author":"JVA Franco","year":"2022","unstructured":"Franco JVA et al (2022) Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis. BJU Int. https:\/\/doi.org\/10.1111\/bju.15653","journal-title":"BJU Int"},{"key":"4440_CR18","doi-asserted-by":"publisher","DOI":"10.4111\/icu.20200392","author":"BHS Ng","year":"2021","unstructured":"Ng BHS, Chung E (2021) A state-of-art review on the preservation of sexual function among various minimally invasive surgical treatments for benign prostatic hyperplasia: Impact on erectile and ejaculatory domains. Investig Clin Urol. https:\/\/doi.org\/10.4111\/icu.20200392","journal-title":"Investig Clin Urol"},{"key":"4440_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7065865","author":"MJ Roehmholdt","year":"2022","unstructured":"Roehmholdt MJ, Bentley DF (2022) Large pelvic hematoma after UroLift\u00ae procedure for treatment of BPH with median lobe. Case Rep Urol. https:\/\/doi.org\/10.1155\/2022\/7065865","journal-title":"Case Rep Urol"},{"key":"4440_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-018-0118-x","author":"D Rukstalis","year":"2019","unstructured":"Rukstalis D et al (2019) Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostat Dis. https:\/\/doi.org\/10.1038\/s41391-018-0118-x","journal-title":"Prostate Cancer Prostat Dis"},{"key":"4440_CR21","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191249","author":"FC Carnevale","year":"2020","unstructured":"Carnevale FC et al (2020) Prostatic artery embolization for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: 10 years\u2019 experience. Radiology. https:\/\/doi.org\/10.1148\/radiol.2020191249","journal-title":"Radiology"},{"key":"4440_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14249","author":"AF Ray","year":"2018","unstructured":"Ray AF et al (2018) Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. https:\/\/doi.org\/10.1111\/bju.14249","journal-title":"BJU Int"},{"key":"4440_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2016.04.001","author":"JM Pisco","year":"2016","unstructured":"Pisco JM et al (2016) Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. https:\/\/doi.org\/10.1016\/j.jvir.2016.04.001","journal-title":"J Vasc Interv Radiol"},{"key":"4440_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10090659","author":"P Svarc","year":"2020","unstructured":"Svarc P, Taudorf M, Nielsen MB, Stroomberg HV, R\u00f8der MA, L\u00f6nn L (2020) Postembolization syndrome after prostatic artery embolization: a systematic review. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics10090659","journal-title":"Diagnostics"},{"key":"4440_CR25","doi-asserted-by":"publisher","DOI":"10.1590\/0100-3984.2021.0021","author":"BF Pilan","year":"2022","unstructured":"Pilan BF, de Assis AM, Moreira AM, de Rodrigues VCP, Carnevale FC (2022) Protection of nontarget structures in prostatic artery embolization. Radiol Bras. https:\/\/doi.org\/10.1590\/0100-3984.2021.0021","journal-title":"Radiol Bras"},{"key":"4440_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-24906-14","author":"C Bouza","year":"2006","unstructured":"Bouza C, L\u00f3pez T, Magro A, Navalpotro L, Amate JM (2006) Systematic review and meta-analysis of transurethral needle ablation in symptomatic benign prostatic hyperplasia. BMC Urol. https:\/\/doi.org\/10.1186\/1471-24906-14","journal-title":"BMC Urol"},{"key":"4440_CR27","doi-asserted-by":"publisher","DOI":"10.1089\/089277902753483745","author":"DM Albala","year":"2002","unstructured":"Albala DM et al (2002) Office-based transurethral microwave thermotherapy using the TherMatrx TMx-2000. J Endourol. https:\/\/doi.org\/10.1089\/089277902753483745","journal-title":"J Endourol"},{"key":"4440_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2004.05155.x","author":"S Masood","year":"2004","unstructured":"Masood S, Djaladat H, Kouriefs C, Keen M, Palmer JH (2004) The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. BJU Int. https:\/\/doi.org\/10.1111\/j.1464-410X.2004.05155.x","journal-title":"BJU Int"},{"key":"4440_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2020.12.022","author":"B Chughtai","year":"2021","unstructured":"Chughtai B et al (2021) The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial. Urology. https:\/\/doi.org\/10.1016\/j.urology.2020.12.022","journal-title":"Urology"},{"key":"4440_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14608","author":"F Porpiglia","year":"2019","unstructured":"Porpiglia F et al (2019) Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up. BJU Int. https:\/\/doi.org\/10.1111\/bju.14608","journal-title":"BJU Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04440-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-023-04440-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04440-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T16:05:21Z","timestamp":1689609921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-023-04440-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["4440"],"URL":"https:\/\/doi.org\/10.1007\/s00345-023-04440-w","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"It was not necessary for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}